News of the WeekBiotechnology

Disease Group Invests in Do-It-Yourself Drugs

+ See all authors and affiliations

Science  09 Jun 2000:
Vol. 288, Issue 5472, pp. 1715-1717
DOI: 10.1126/science.288.5472.1715b

You are currently viewing the summary.

View Full Text

Summary

On 31 May, the Cystic Fibrosis (CF) Foundation of Bethesda, Maryland, announced that it will invest at least $30 million in a small biotech firm, Aurora Biosciences of San Diego, to identify compounds that might prove useful in treating CF. This project, fueled initially by a donation of $20 million from the Bill and Melinda Gates Foundation, marks a new departure in the growing trend of patient groups taking charge of biomedical research.

Related Content